U.S. Physical Therapy, Inc. (NYSE:USPH) Director Sells $113,355.84 in Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) Director Nancy Ham sold 1,172 shares of the stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.72, for a total value of $113,355.84. Following the sale, the director now owns 1,112 shares in the company, valued at $107,552.64. The trade was a 51.31 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

U.S. Physical Therapy Stock Down 1.8 %

NYSE:USPH opened at $90.18 on Friday. The company has a quick ratio of 1.88, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63. The stock’s fifty day simple moving average is $84.09 and its 200-day simple moving average is $91.25. The firm has a market capitalization of $1.36 billion, a P/E ratio of 95.94, a P/E/G ratio of 4.15 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). The company had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. U.S. Physical Therapy’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.76 earnings per share. Equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.95%. U.S. Physical Therapy’s dividend payout ratio is 187.23%.

Institutional Trading of U.S. Physical Therapy

A number of large investors have recently made changes to their positions in the company. Benjamin Edwards Inc. lifted its holdings in U.S. Physical Therapy by 117.6% during the third quarter. Benjamin Edwards Inc. now owns 5,885 shares of the company’s stock worth $498,000 after acquiring an additional 3,181 shares in the last quarter. Rockefeller Capital Management L.P. increased its stake in U.S. Physical Therapy by 18.8% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock worth $13,578,000 after purchasing an additional 25,393 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after buying an additional 956 shares during the period. BNP Paribas Financial Markets increased its position in shares of U.S. Physical Therapy by 283.0% during the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after acquiring an additional 12,445 shares in the last quarter. Finally, Quantbot Technologies LP lifted its position in U.S. Physical Therapy by 57.6% in the 3rd quarter. Quantbot Technologies LP now owns 10,876 shares of the company’s stock valued at $920,000 after acquiring an additional 3,973 shares in the last quarter.

Analysts Set New Price Targets

Several research firms have recently commented on USPH. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Bank of America reaffirmed a “neutral” rating and issued a $90.00 target price (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. Finally, Barrington Research reissued an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research note on Thursday, November 7th.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.